KDR and neoplasm: Although the sub-optimal dose of VEGFR blockade only showed a trend inhibitory effect on neovascularization and tumor proliferation, compared with the control IgG group (Fig. 5E–F), the combination treatment had a strong anti-angiogenesis effect (Fig. 5E).